Fundings for Seattle-area startups lagged at the end of 2024, according to a new PitchBook-NVCA report, but they're off to a ...

The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

US health systems and Regeneron Genetics Center launch the Truveta Genome Project, a $320M initiative to sequence up to 10M ...

The health systems, Illumina, and Regeneron have invested $320M in what Truveta calls the largest and most diverse database ...

Seattle-based Umoja Biopharma has raised a $100 million Series C round. With the funding, announced Tuesday, Umoja wants to ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare Conference. Shares of the company moved up in pre-market trading on Jan. 14.

Umoja Biopharma announced a $100 million Series C round that will help the Seattle-based company further develop its CAR ...

Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

The health data company, based in Bellevue, Washington, plans to collect leftover specimens from consenting patients who get routine health care at participating facilities, Stat reported. Also in the ...

Health data company Truveta is partnering with health systems and drugmakers to create a massive database of genetic data ...

The Truveta Genome Project aims to establish the world’s largest and most diverse database of genetic information.

Seventeen health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence and ...